You start off by saying "just for a by it of fun". Then you end with using this ridiculously hypothetical scenario to conclude "massive upside" and justifying management's latest round of optimisation studies and cost reduction initiatives to 'maximise shareholder value'. Crazy stuff.
In my experience, when these types of statements are made, it inevitably means indescriminate cost cutting and a lower quality outcome project outcome. I hope this is not the case with Goulamina.
BGS Price at posting:
17.0¢ Sentiment: None Disclosure: Not Held